Trademark Search  /  EVEREST MEDICINES

EVEREST MEDICINES

○ Dead · Abandoned

U.S. federal trademark · Serial No. 88584513

Mark
EVEREST MEDICINES
Status
Abandoned
Serial Number
88584513
Filing Date
August 19, 2019
Class(es)
Class 001, Class 005

Owners

EverNov Medicines Limited
16 · Shanghai, CN
EverNov Medicines Limited
16 · Shanghai, CN

Goods & Services

Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs

Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical research; pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "EVEREST MEDICINES" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.